BRUSSELS, Oct 8 (Reuters) - The European Commission said on
Thursday it had sealed a supply deal with Johnson & Johnson
for the supply of its potential COVID-19 vaccine for up
to 400 million people.
This is the third advance purchase contract signed by the EU
with makers of COVID-19 vaccines after deals with AstraZeneca
(Reporting by Francesco Guarascio; editing by Jason Neely